Cooper Companies (NASDAQ:COO) Rating Reiterated by Stifel Nicolaus

Cooper Companies (NASDAQ:COO)‘s stock had its “buy” rating restated by Stifel Nicolaus in a research report issued on Thursday, Benzinga reports. They currently have a $115.00 price objective on the medical device company’s stock, up from their prior price objective of $110.00. Stifel Nicolaus’ price objective suggests a potential upside of 8.77% from the stock’s previous close.

Other equities research analysts have also issued research reports about the stock. Piper Sandler upped their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday. Wells Fargo & Company upped their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday. Robert W. Baird lifted their target price on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Thursday. Finally, Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and raised their price target for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and a consensus target price of $113.61.

Cooper Companies Price Performance

Shares of COO stock opened at $105.73 on Thursday. Cooper Companies has a twelve month low of $75.93 and a twelve month high of $106.95. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. The stock’s 50 day simple moving average is $91.53 and its 200 day simple moving average is $94.19. The company has a market capitalization of $21.05 billion, a price-to-earnings ratio of 62.19, a PEG ratio of 2.34 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. During the same quarter last year, the firm posted $0.84 EPS. The company’s revenue was up 7.8% on a year-over-year basis. As a group, research analysts predict that Cooper Companies will post 3.57 EPS for the current year.

Hedge Funds Weigh In On Cooper Companies

A number of large investors have recently made changes to their positions in COO. Benjamin F. Edwards & Company Inc. boosted its holdings in Cooper Companies by 248.6% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after purchasing an additional 174 shares during the period. Innealta Capital LLC acquired a new stake in shares of Cooper Companies during the 2nd quarter worth $25,000. Covestor Ltd raised its stake in Cooper Companies by 305.9% in the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after purchasing an additional 208 shares in the last quarter. Crewe Advisors LLC grew its stake in Cooper Companies by 286.4% during the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after buying an additional 252 shares in the last quarter. Finally, Global Retirement Partners LLC raised its position in shares of Cooper Companies by 358.6% in the 1st quarter. Global Retirement Partners LLC now owns 321 shares of the medical device company’s stock valued at $33,000 after buying an additional 251 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.